Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 01:38 pm IST
Share
Zhejiang Tailin BioEngineering Co.,Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 71.53 million compared to CNY 48.04 million a year ago. Revenue was CNY 71.53 million compared to CNY 48.04 million a year ago. Net income was CNY 13.93 million compared to CNY 9.6 million a year ago. Basic earnings per share from continuing operations was CNY 0.1688 compared to CNY 0.1125 a year ago. Diluted earnings per share from continuing operations was CNY 0.1688 compared to CNY 0.1125 a year ago.
Zhejiang Tailin Bioengineering Co., Ltd. is a China-based company mainly engaged in pharmaceutical equipment business. The Company's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The Company distributes its products within domestic market and to overseas markets.
ZHEJIANG TAILIN BIOENGINEERING CO.,LTD 
